Driehaus Capital Management LLC lifted its position in Docusign Inc. (NASDAQ:DOCU - Free Report) by 31.0% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 287,428 shares of the company's stock after purchasing an additional 67,972 shares during the quarter. Driehaus Capital Management LLC owned approximately 0.14% of Docusign worth $23,397,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in DOCU. Wellington Management Group LLP boosted its position in shares of Docusign by 372.5% in the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock valued at $148,714,000 after purchasing an additional 1,440,269 shares during the period. Pacer Advisors Inc. lifted its position in Docusign by 809.6% during the 1st quarter. Pacer Advisors Inc. now owns 1,167,290 shares of the company's stock worth $95,017,000 after acquiring an additional 1,038,962 shares during the period. Northern Trust Corp lifted its position in Docusign by 77.2% during the 4th quarter. Northern Trust Corp now owns 1,984,378 shares of the company's stock worth $178,475,000 after acquiring an additional 864,408 shares during the period. Nuveen LLC acquired a new stake in Docusign during the 1st quarter worth approximately $50,459,000. Finally, Victory Capital Management Inc. lifted its position in Docusign by 251.0% during the 1st quarter. Victory Capital Management Inc. now owns 734,588 shares of the company's stock worth $59,795,000 after acquiring an additional 525,294 shares during the period. 77.64% of the stock is owned by institutional investors and hedge funds.
Docusign Stock Up 2.6%
NASDAQ DOCU traded up $1.93 during mid-day trading on Wednesday, hitting $76.00. The stock had a trading volume of 1,878,946 shares, compared to its average volume of 2,565,978. Docusign Inc. has a 52-week low of $54.31 and a 52-week high of $107.86. The company has a market cap of $15.36 billion, a price-to-earnings ratio of 14.37, a P/E/G ratio of 28.61 and a beta of 1.02. The company has a 50 day simple moving average of $75.43 and a 200 day simple moving average of $79.56.
Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings data on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.09. Docusign had a return on equity of 14.27% and a net margin of 36.50%.The firm had revenue of $763.65 million during the quarter, compared to the consensus estimate of $748.79 million. During the same period last year, the business posted $0.82 EPS. Docusign's quarterly revenue was up 7.6% on a year-over-year basis. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, equities analysts anticipate that Docusign Inc. will post 1.17 earnings per share for the current fiscal year.
Docusign declared that its board has authorized a stock repurchase program on Thursday, June 5th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to reacquire up to 6.6% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board believes its stock is undervalued.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on the company. Wall Street Zen cut Docusign from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. Needham & Company LLC reaffirmed a "hold" rating on shares of Docusign in a research report on Friday, June 6th. Citigroup decreased their price objective on Docusign from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Monday, June 9th. JPMorgan Chase & Co. cut their target price on Docusign from $81.00 to $77.00 and set a "neutral" rating for the company in a research note on Friday, June 6th. Finally, Robert W. Baird cut their target price on Docusign from $93.00 to $85.00 and set a "neutral" rating for the company in a research note on Friday, June 6th. Four analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Hold" and a consensus price target of $89.77.
Check Out Our Latest Stock Analysis on Docusign
Insider Transactions at Docusign
In related news, CEO Allan C. Thygesen sold 40,000 shares of the firm's stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $77.51, for a total value of $3,100,400.00. Following the completion of the transaction, the chief executive officer directly owned 143,983 shares of the company's stock, valued at $11,160,122.33. This trade represents a 21.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Teresa Briggs sold 534 shares of the firm's stock in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $74.37, for a total value of $39,713.58. Following the completion of the transaction, the director directly owned 8,805 shares of the company's stock, valued at $654,827.85. The trade was a 5.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 78,552 shares of company stock valued at $5,983,631. Company insiders own 1.66% of the company's stock.
Docusign Company Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles

Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.